Bernard Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.5M Buy
9,244
+27
+0.3% +$27.4K 3.63% 6
2025
Q4
$9.91M Sell
9,217
-500
-5% -$478K 4.02% 4
2025
Q3
$7.41M Sell
9,717
-274
-3% -$204K 3.1% 7
2025
Q2
$7.79M Sell
9,991
-989
-9% -$769K 3.61% 7
2025
Q1
$9.07M Sell
10,980
-96
-0.9% -$79.9K 4.43% 5
2024
Q4
$8.55M Buy
+11,076
New +$9.17M 4.02% 6

Other funds holding LLY

Bernard Wealth Management's LLY Position: Q1 2026 in Review

Bernard Wealth Management increased its Eli Lilly (LLY) stake by 0.29% in Q1 2026, buying an estimated $27.4K and bringing the position to 9,244 shares worth $8.5M. The position accounts for 3.63% of the portfolio, ranked #6.

Bernard Wealth Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.91M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bernard Wealth Management held 9,244 shares of Eli Lilly worth $8.5M as of Q1 2026.
  • Bernard Wealth Management bought 27 Eli Lilly shares in Q1 2026, an estimated $27.4K.
  • Eli Lilly made up 3.63% of Bernard Wealth Management's portfolio in Q1 2026, its #6 holding.
  • Bernard Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Bernard Wealth Management's Eli Lilly position peaked at $9.91M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bernard Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.